SCHEMBL6985580

SCHEMBL6985580

O=C1CCCCN1c1ccc(Br)c(Br)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD9 Q9H8M2 1/20 0.49
ALDH1A1 P00352 4/20 0.47
HPGD P15428 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
AKR1C3 P42330 2/20 0.45
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
TSHR P16473 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 1/20 0.44
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.41
IDO1 P14902 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11819949 0.87 ALDH1A1 (0.40) BRD9ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL6982671 0.87 BRD9 (0.47) BRD9ALDH1A1HPGDCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL18955263 0.85 BRD9 (0.46) BRD9ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL6986476 0.85 BRD9 (0.46) BRD9ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL16178892 0.85 BRD9 (0.46) BRD9ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL29130908 0.82 MAPT (0.48) BRD9ALDH1A1HPGDTSHRMAPT
SCHEMBL26920629 0.81 SLC6A2 (0.50) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6523537 0.81 ALDH1A1 (0.50) BRD9ALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL10112811 0.80 IDO1 (0.57) BRD9ALDH1A1HPGDAKR1C3TSHR
SCHEMBL7812949 0.80 LMNA (0.54) BRD9ALDH1A1HPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed